Gilead Sciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2012
Total Assets: $21.24B
Liabilities Breakdown FY2012
Total Liabilities: $11.94B
Asset Breakdown
Total Assets: $21.24B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.80B | 8.5% |
| Accounts Receivable | $1.75B | 8.2% |
| Inventory | $1.74B | 8.2% |
| Property, Plant & Equipment | $1.10B | 5.2% |
| Goodwill | $1.06B | 5.0% |
| Intangible Assets | $11.74B | 55.3% |
| Other Assets | $2.04B | 9.6% |
Liabilities Breakdown
Total Liabilities: $11.94B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.33B | 11.1% |
| Long-Term Debt | $7.05B | 59.1% |
| Other Liabilities | $3.56B | 29.8% |